Log in | Register

Improved clinical and economic outcomes in severe bronchiolitis with pre-emptive nCPAP ventilatory strategy

Sandrine Essouri| Marie Laurent| Laurent Chevret| Philippe Durand| Emmanuelle Ecochard| Vincent Gajdos| Denis Devictor| Pierre Tissières
Original
Volume 40, Issue 1 / January , 2014

Pages 84 - 91

Abstract

Purpose

Severe bronchiolitis is the leading cause of admission to the pediatric intensive care unit (PICU). Nasal continuous positive airway pressure (nCPAP) has become the primary respiratory support, replacing invasive mechanical ventilation (MV). Our objective was to evaluate the economic and clinical consequences following implementation of this respiratory strategy in our unit.

Methods

This was a retrospective cohort analysis of 525 infants with bronchiolitis requiring respiratory support and successively treated during two distinct periods with invasive MV between 1996 and 2000, P1 (n = 193) and nCPAP between 2006 and 2010, P2 (n = 332). Costs were estimated using the hospital cost billing reports.

Results

Patients’ baseline characteristics were similar between the two periods. P2 is associated with a significant decrease in the length of ventilation (LOV) (4.1 ± 3.5 versus 6.9 ± 4.6 days, p < 0.001), PICU length of stay (LOS) (6.2 ± 4.6 versus 9.7 ± 5.5 days, p < 0.001) and hospital LOS. nCPAP was independently associated with a shorter duration of ventilatory support than MV (hazard ratio 1.8, 95 % CI 1.5–2.2, p < 0.001). nCPAP was also associated with a significant decrease in ventilation-associated complications, and less invasive management. The mean cost of acute viral bronchiolitis-related PICU hospitalizations was significantly decreased, from 17,451 to 11,205 € (p < 0.001). Implementation of nCPAP led to a reduction of the total annual cost of acute viral bronchiolitis hospitalizations of 715,000 €.

Conclusion

nCPAP in severe bronchiolitis is associated with a significant improvement in patient management as shown by the reduction in invasive care, LOV, PICU LOS, hospital LOS, and economic burden.

Keywords

References

  1. Simoes EA (1999) Respiratory syncytial virus infection. Lancet 354(9181):847–852
    • View reference on PubMed
    • View reference on publisher's website
  2. Simoes EA (1999) Respiratory syncytial virus and subsequent lower respiratory tract infections in developing countries: a new twist to an old virus. J Pediatr 135(6):657–661
    • View reference on PubMed
    • View reference on publisher's website
  3. Greenough A (2009) Role of ventilation in RSV disease: CPAP, ventilation, HFO, ECMO. Paediatr Respir Rev 10(Suppl 1):26–28
    • View reference on PubMed
    • View reference on publisher's website
  4. Shay DK et al (1999) Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 282(15):1440–1446
    • View reference on PubMed
    • View reference on publisher's website
  5. Leader S, Kohlhase K (2003) Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 143(5 Suppl):S127–S132
    • View reference on PubMed
    • View reference on publisher's website
  6. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723–1729
    • View reference on PubMed
    • View reference on publisher's website
  7. Essouri S et al (2011) Optimal level of nasal continuous positive airway pressure in severe viral bronchiolitis. Intensive Care Med 37(12):2002–2007
  8. Levine DA et al (2004) Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 113(6):1728–1734
    • View reference on PubMed
    • View reference on publisher's website
  9. Simoes EA, Carbonell-Estrany X (2003) Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 22(2 Suppl):S13–S18 (discussion S18–20)
    • View reference on PubMed
  10. Deshpande SA, Northern V (2003) The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 88(12):1065–1069
    • View reference on PubMed
    • View reference on publisher's website
  11. Lebel MH et al (1989) Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch Dis Child 64(10):1431–1437
    • View reference on PubMed
    • View reference on publisher's website
  12. Smyth RL, Openshaw PJ (2006) Bronchiolitis. Lancet 368(9532):312–322
    • View reference on PubMed
    • View reference on publisher's website
  13. Jorgensen J et al (2007) Incidence of and risk factors for airway complications following endotracheal intubation for bronchiolitis. Otolaryngol Head Neck Surg 137(3):394–399
    • View reference on PubMed
    • View reference on publisher's website
  14. Beasley JM, Jones SE (1981) Continuous positive airway pressure in bronchiolitis. Br Med J (Clin Res Ed) 283(6305):1506–1508
    • View reference on publisher's website
  15. Soong WJ, Hwang B, Tang RB (1993) Continuous positive airway pressure by nasal prongs in bronchiolitis. Pediatr Pulmonol 16(3):163–166
    • View reference on PubMed
    • View reference on publisher's website
  16. Thia LP et al (2008) Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis. Arch Dis Child 93(1):45–47
    • View reference on PubMed
    • View reference on publisher's website
  17. Campion A et al (2006) Non-invasive ventilation in infants with severe infection presumably due to respiratory syncytial virus: feasibility and failure criteria. Arch Pediatr 13(11):1404–1409
    • View reference on PubMed
    • View reference on publisher's website
  18. Larrar S et al (2006) Effects of nasal continuous positive airway pressure ventilation in infants with severe acute bronchiolitis. Arch Pediatr 13(11):1397–1403
    • View reference on PubMed
    • View reference on publisher's website
  19. Ganu SS et al (2012) Increase in use of non-invasive ventilation for infants with severe bronchiolitis is associated with decline in intubation rates over a decade. Intensive Care Med 38(7):1177–1183
  20. Cavari Y et al (2012) Non invasive positive pressure ventilation in infants with respiratory failure. Pediatr Pulmonol 47(10):1019–1025
    • View reference on PubMed
    • View reference on publisher's website
  21. Cambonie G et al (2008) Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe acute viral bronchiolitis. Intensive Care Med 34(10):1865–1872
  22. Milesi C et al (2013) Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study. Intensive Care Med 39(6):1088–1094
  23. Javouhey E et al (2008) Non-invasive ventilation as primary ventilatory support for infants with severe bronchiolitis. Intensive Care Med 34(9):1608–1614
  24. Shu XO et al (1994) Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Childrens Cancer Group. Cancer Epidemiol Biomarkers Prev 3(8):645–653
    • View reference on PubMed
  25. Greenes DS, Harper MB (1999) Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J 18(3):258–261
    • View reference on PubMed
    • View reference on publisher's website
  26. Vogel AM et al (2003) Variations in bronchiolitis management between five New Zealand hospitals: can we do better? J Paediatr Child Health 39(1):40–45
    • View reference on PubMed
    • View reference on publisher's website
  27. Kabir ML et al (2003) Evaluation of hospitalized infants and young children with bronchiolitis—a multi centre study. Mymensingh Med J 12(2):128–133
    • View reference on PubMed
  28. Thorburn K et al (2006) High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 61(7):611–615
    • View reference on PubMed
    • View reference on publisher's website
  29. Kneyber MC et al (2005) Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med 31(5):680–685
  30. Girou E et al (2003) Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA 290(22):2985–2991
    • View reference on PubMed
    • View reference on publisher's website
  31. Pelletier AJ, Mansbach JM, Camargo CA Jr (2006) Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 118(6):2418–2423
    • View reference on PubMed
    • View reference on publisher's website
  32. Chandra D et al (2012) Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med 185(2):152–159
    • View reference on PubMed
    • View reference on publisher's website
  33. Willson DF, Landrigan CP, Horn SD, Smout RJ (2003) Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 143(Suppl 5):S142–S149
    • View reference on PubMed
    • View reference on publisher's website
  34. Howard TS, Hoffman LH, Stang PE, Simoes EA (2000) Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J Pediatr 137(2):227–232
    • View reference on PubMed
    • View reference on publisher's website
  35. Katz B, Lo J, Sorrentino M (2003) Costs of respiratory syncytial virus infection at a tertiary care children’s hospital. Pharm Ther 28(5):343–345

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement